Your browser doesn't support javascript.
loading
Molecular characterisation of Hepatitis E virus isolates from north India.
Bhatnagar, Nidhi; Prakash, Shantanu; Ramakrishna, Vangala; Khan, Danish Nasar; Shrivastava, Shakti Saumnam; Venkatesh, Vimala; Reddy, D Himanshu; Jain, Amita.
Afiliação
  • Bhatnagar N; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India. Electronic address: nidhi2211@gmail.com.
  • Prakash S; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Ramakrishna V; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Khan DN; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Shrivastava SS; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Venkatesh V; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Reddy DH; Department of Medicine, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Jain A; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India. Electronic address: amita602002@yahoo.com.
Indian J Med Microbiol ; 40(1): 91-95, 2022.
Article em En | MEDLINE | ID: mdl-34600752
PURPOSE: Hepatitis E virus (HEV) is responsible for >50% of acute viral hepatitis (AVH) in developing countries. It has 4 major genotypes and various subtypes which vary in geographical distribution, clinical manifestations and epidemiological patterns. This study was conducted to characterise HEV isolates from north India to study the effect of host and viral factors on HEV infection. METHODS: Serum samples collected from 536 AVH patients admitted to Department of Medicine, King George's Medical University, Lucknow from July 2016 to June 2017 were screened for anti HEV IgM, anti HAV IgM, HBsAg and anti HCV antibodies using commercial ELISA kits. Samples either positive for anti HEV IgM antibodies (n â€‹= â€‹204) or negative for all 4 hepatotropic viruses (n â€‹= â€‹37) were enrolled and tested by real time PCR for HEV RNA. HEV RNA positive samples with high viral load were further subjected to nested PCR for amplification of capsid gene. Sequencing and phylogenetic analysis were performed. HEV strains isolated from this study were deposited to GenBank under accession numbers MG571274 to MG571283. RESULTS: Anti HEV IgM positivity was observed among 38% clinically suspected AVH cases. HEV RNA was detected in 31.8% seropositive HEV cases and additional 3 seronegative cases. Males outnumbered females and the most affected age group was of young adults. Maximum number of cases were seen during the months of June to September. Phylogenetic analysis showed that HEV strains in our study belonged to genotype 1a. Mortality in HEV infected pregnant females was 23.5% as compared to 2.4% in non-pregnant females. Adverse fetal outcome was recorded in 51% of HEV infected pregnancies. CONCLUSIONS: HEV genotype 1a is prevalent in our setting. HEV during pregnancy is associated with adverse maternal and fetal outcome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Vírus da Hepatite E / Hepatite E Limite: Adult / Female / Humans / Male / Pregnancy País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Vírus da Hepatite E / Hepatite E Limite: Adult / Female / Humans / Male / Pregnancy País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article